In experimental ICH models, melatonin has also been associated with improved motor outcomes and the preservation of the corticospinal tract, along with the attenuation of hyperglycemia-induced brain injury via the PPARδ/PGC-1α pathway [36,37]. Here, PPARD is linked to injury.